Name: OHSU seeking participants for Phase 3 COVID-19 vaccine trial
Brand: koin.com
SKU: koin-com-140
Availability: OnlineOnly

critic

OHSU seeking participants for Phase 3 COVID-19 vaccine trial

preview

PORTLAND, Ore. (KOIN) — is recruiting Portlanders for a COVID-19 vaccine trial.OHSU is looking for Portland-area residents to participate in a research study evaluating a potential vaccine developed by Oxford University and AstraZeneca, referred to as the AZD1222 COVID-19&nbsp;vaccine study. OHSU is the only institution in the state involved in a Phase 3 clinical trial for the potential vaccine.“Oregon Health &amp; Science University is proud to contribute to the world’s most pressing challenge right now: identifying a safe and effective COVID-19 vaccine for everyone,” OHSU President Danny Jacobs said. “We’re asking Portland-area residents to volunteer for this trial and help bring all of us closer to stopping this devastating pandemic.”Dr. Marcel Curlin, OHSU’s lead researcher for the clinical study, said AstraZeneca’s vaccine is much safer than vaccines in the past because the actual COVID virus is not used to make it. Asked if he would be comfortable taking this vaccine, Curlin had a short and ready answer.“Yes, I would.”He explained that what they’re doing “is something carefully designed to be safe and educate the immune system without being exposed to COVID. So that’s something different and I would personally be comfortable taking these vaccines.”The trial is seeking a total of 30,000 participants to enroll. The participants will evaluate thesafety and effectiveness of the vaccine, with two injections administered about four weeks apart. Patients will then be monitored for two years.According to OHSU, the study will strive to “enroll a diverse group of trial participants, and prioritizes the enrollment of individuals who are older than 55 years and Black, Indigenous and People of Color” in order to ensure the vaccine works well for the broadest group of people possible.OHSU says participants must be 18 or older, not be pregnant, have either stable medical conditions or no medical issues, have not been previously diagnosed with COVID-19 and should live withinabout 1.5 hours of OHSU’s Marquam Hill/South Waterfront campus. Those interested in enrolling can visit or call 888.822.7839.More than 70,000 COVID-19 cases have been reported in Oregon since February; more than 900 Oregonians have lost their lives to the virus.Follow KOIN 6 for the latest news and weather for iPhone, iPad and Android. You can also follow us on , and , and sign up for our .× Close Ad

PORTLAND, Ore. (KOIN) — is recruiting Portlanders for a COVID-19 vaccine trial.OHSU is looking for Portland-area residents to participate in a research study evaluating a potential vaccine developed by Oxford University and AstraZeneca, referred to as the AZD1222 COVID-19&nbsp;vaccine study. OHSU is the only institution in the state involved in a Phase 3 clinical trial for the potential vaccine.“Oregon Health &amp; Science University is proud to contribute to the world’s most pressing challenge right now: identifying a safe and effective COVID-19 vaccine for everyone,” OHSU President Danny...

public

Wayne Havrelly

koin.com

Credible

Speculation

Anecdotal Evidence

Generalization

Stacking the Deck

Appeal to Authority

Straw Man

Slippery Slope

Emotional Appeal

Red Herring

False Dilemma

Illogical

Moral Equivalency

Ad Hominem

Correlation w/o Causation

Semantics

Begging the Question

Faulty Analogy

Non Sequitur

Bandwagon

Dogmatism

Failing Occam's Razor

Biased

Pure Opinion

Hit Piece

Racial Bias

National Bias

Religious Bias

Financial Incentive

Political Agenda

Gender Bias

Misused Image/Video

Study Misinterpreted

Mistake

Misused Term

Science Misrepresented

Factual Error

Satire

Surface Level

Lack of Reliable Sources

Sensational

Not Credible

Investigative

Balanced

Well Sourced

Great Context

sports

entertainment

U.S.

international

business

technology

science

culture

politics

media

health

OHSU seeking participants for Phase 3 COVID-19 vaccine trial

No article scores yet.

CRITIC REVIEWS

PUBLIC REVIEWS